Auteur A. GALLEGOS
|
|
Documents disponibles écrits par cet auteur (20)
Ajouter le résultat à votre sélection Affiner la recherche
Europol ; L. LANIEL ; C. CARPENTIER ; C. COSTA STORTI ; A. GALLEGOS ; D. LOPEZ ; C. MARTEL ; L. ROYUELA ; R. SEDEFOV ; R. SIMON ; J. WRIGHT ; F. ZOBEL ; P. GRIFFITHS | 2010
RapportThis report provides an overview of what is known about how cocaine is produced and trafficked into the European Union. It aims to provide a better understanding of the actors involved, the routes taken, and the scale of the problem in Europe. I[...]
This publication presents 30 profiles of the national early warning systems on new psychoactive substances in operation in Europe in 2011. The early warning system on new psychoactive substances is a multidisciplinary network consisting of 30 Eu[...]
B. PULVER ; S. FISCHMANN ; A. GALLEGOS ; R. CHRISTIE | 2024
Dans Drug Testing and Analysis (Vol.16, n°12, December 2024) Article : PériodiqueCathinones are often sold as "legal" alternatives to controlled stimulants such as amphetamine, MDMA and cocaine. Cathinones are the second largest group of new psychoactive substances (NPS), with close to 170 monitored by the European Monitorin[...]
B. PULVER ; S. FISCHMANN ; A. GALLEGOS ; R. CHRISTIE | 2023
Dans Drug Testing and Analysis (Vol.15, n°3, March 2023) Article : PériodiqueSynthetic cannabinoids (SCs), often sold as "legal" replacements for cannabis, are the largest group of new psychoactive substances monitored by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Currently, close to 240 struct[...]
These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 20[...]
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. CHRISTIE ; S. SOLA ; A. ALMEIDA ; R. JORGE ; J. DE MORAIS ; R. SEDEFOV | 2018
RapportIn this update from the EU Early Warning System, the EMCDDA aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency's early warning and risk-assessment activities. This report cov[...]
R. ANDREWS ; R. JORGE ; R. CHRISTIE ; A. GALLEGOS | 2023
Dans Drug Testing and Analysis (Vol.15, n°4, April 2023) Article : PériodiqueWith new synthetic cannabinoids (SC) appearing on the European drug market every year, early warning systems are key to detect, monitor, and respond to threats posed by them. The European Union Early Warning System (EU EWS) implemented by the Eu[...]
OEDT = EMCDDA ; I. UJVARY ; M. EVANS-BROWN ; A. GALLEGOS ; G. PLANCHUELO ; J. DE MORAIS ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | 2023
RapportThe markets for hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSC) are rapidly evolving areas with relatively limited information currently available. The European situation presented in Section 1 can only provide an overvie[...]
P. GRIFFITHS ; R. SEDEFOV ; A. GALLEGOS ; D. LOPEZ | 2010
Dans Addiction (Vol.105, n°6, June 2010) Article : Périodique'Spice' is a herbal mixture sold on the internet, samples of which have been found to contain new synthetic drugs which produce effects similar to cannabis. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)'s early warning sys[...]
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. SEDEFOV ; A. ALMEIDA ; R. CHRISTIE ; P. DUQUE ; A. GALLEGOS ; R. JORGE ; J. DE MORAIS | 2020
RapportThis publication presents the data and findings of the risk assessment on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on [...]
P. GRIFFITHS ; D. LOPEZ ; R. SEDEFOV ; A. GALLEGOS ; B. HUGHES ; A. NOOR ; L. ROYUELA | 2010
Dans Journal of Ethnopharmacology (Vol.132, n°3, December 2010) Article : PériodiqueAIM OF THE STUDY: To review the information available on the use of khat (Catha edulis) in the EU, and to assess the future use of this drug and related substances. MATERIAL AND METHODS: Khat is not controlled by international law and it has not[...]
H. LOPEZ-PELAYO ; J. VICENTE ; A. GALLEGOS ; A. McAULEY ; Y. BUYUK ; M. WHITE ; I. GIRAUDON | 2021
Dans Emerging Trends in Drugs, Addictions, and Health (Vol.1, 2021) Article : PériodiqueBackground-Aims: New psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the drug conventions of the United Nations. In the last 10 years, numerous NPS have been identified in Europe but there is no co[...]
OEDT = EMCDDA ; V. AUWÄRTER ; J. DE MORAIS ; A. GALLEGOS ; M. EVANS-BROWN ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | 2021
RapportThis report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System. The aims of this report are to strengthen situational awareness of new benzodiazepines in E[...]
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. CHRISTIE ; R. JORGE ; J. DE MORAIS ; A. ALMEIDA ; R. SEDEFOV | 2020
RapportIn this update from the the EU Early Warning System aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency's early warning and risk-assessment activities. The report covers the p[...]
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; W. FRANCIS ; R. CHRISTIE ; A. CUNNINGHAM ; J. SEKULA ; A. ALMEIDA ; R. SEDEFOV | 2015
RapportFRANÇAIS : De nouvelles substances psychoactives (NSP ou «nouvelles drogues») ont été détectées dans l'Union européenne l'année dernière au rythme de deux par semaine environ. Au total, 101 nouvelles substances ont été signalées au système d'al[...]
Historique